ANXA2 and esophageal squamous cell carcinoma: To delve even deeper, the authors performed in vitro experiments, and demonstrated that ANXA2 overexpression in ESCC cells suppresses their invasion and migration potential, as well as their proliferation, arresting the cell cycle at the G2 phase, although without causing apoptosis.